Co-Clinical Research Resource for Imaging Tumor Associated Macrophages
肿瘤相关巨噬细胞成像联合临床研究资源
基本信息
- 批准号:10688045
- 负责人:
- 金额:$ 63.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AftercareAnimal ModelBiological MarkersBlocking AntibodiesCD47 geneCell physiologyCell surfaceCellsClinicClinicalClinical ResearchClinical TrialsClinical Trials DesignCommunitiesComputer softwareConsensusDarknessDataData PoolingDevelopmentDiagnosisDiseaseEatingElementsFDA approvedGoalsGrowthHealthcareHistologyHourImageImaging DeviceImaging TechniquesImmunotherapyIndustryInjectionsInstitutionIntegral Membrane ProteinIntravenousInvestigationLearningMagnetic Resonance ImagingMalignant NeoplasmsMapsMethodsMonitorMonoclonal AntibodiesMonoclonal Antibody TherapyMulti-Institutional Clinical TrialNecrosisNeoplasm MetastasisOperative Surgical ProceduresOutcome MeasurePatient-Focused OutcomesPatientsPhagocytesPharmaceutical PreparationsPhasePhase I Clinical TrialsPositioning AttributePrediction of Response to TherapyProtocols documentationReference StandardsReproducibilityResearchResearch PersonnelResourcesSHPS-1 proteinSignal TransductionSpeedStandardizationTestingTherapeuticTimeTranslatingTumor-associated macrophagesWorkanticancer activitycancer cellcancer clinical trialcancer imagingcancer immunotherapycancer therapychemotherapyclinical applicationclinical imagingclinical investigationclinical translationco-clinical trialcomparative efficacydesignefficacy studyferumoxytolfirst-in-humanimaging approachimaging biomarkerimaging modalityimaging studyimmunomodulatory therapiesimprovedimproved outcomein vivointerestintravenous injectioniron oxide nanoparticleiron supplementmouse modelnanoparticleneoplastic cellnext generationnovelnovel therapeuticsoff-label useosteosarcomapatient populationpediatric patientspre-clinicalpreclinical imagingpreclinical studypredicting responsequantitative imagingreceptorresponsesarcomatreatment responsetreatment stratificationtumortumor eradicationtumor growthtumor progressionuptakeweb-accessible
项目摘要
Co-Clinical Research Resource for Imaging Tumor Associated Macrophages
ABSTRACT
The development of quantitative imaging (QI) methods for monitoring cancer therapy response has
been transformative for the development of novel cancer therapeutics. QI efforts have positioned imaging as
a key element in the design of clinical trials for cancer therapy response assessment. Hence, there is
increased interest by the academic and industry sectors to use web accessible research resources and
develop consensus approaches to validate QI methods for the next generation of clinical trials. This is
particularly relevant for assessment of cancer immunotherapy, since immunotherapy does not lead to a
decrease in tumor size, at least not in the immediate post-treatment phase. Therefore, we urgently need new
QI tools that can monitor tumor response to novel immunotherapies. The overall goal of our project is to
optimize and validate preclinical and clinical imaging techniques for in vivo quantification of tumor
associated macrophages (TAM) in osteosarcomas. Recent evidence has shown that the abundant TAM
response in the microenvironment of bone sarcomas can be employed to directly attack cancer cells.
Blockade of the cell surface molecule CD47 expressed on sarcoma cells resulted in activation of phagocytic
anti-cancer activity from TAM and efficiently eradicated tumor cells in mouse models of osteosarcoma. 26
Preclinical studies have been finalized and a multi-center phase I clinical trial is currently being planned, with
expected start date in 2021. To solve the unmet clinical need for a QI tool to monitor response to new TAM-
modulating therapies, our team developed a quantitative TAM imaging test, which relies on intravenous
injection of the iron supplement ferumoxytol. Ferumoxytol is composed of iron oxide nanoparticles, which are
phagocytosed by TAM and can be quantified with T2*-weighted MRI 45. Since ferumoxytol is FDA-approved
and can be used “off label” as a TAM biomarker, it is immediately clinically available. We showed that
ferumoxytol-MRI can detect TAM in osteosarcomas in mouse models 21 and patients 25. Through this
project, we will (a) optimize and validate pre-clinical quantitative imaging methods for TAM imaging in
an established mouse model of osteosarcoma, (b) implement the optimized methods in a co-clinical
trial in patients with osteosarcoma who are undergoing immunotherapy with CD47 mAb, and finally
(c) populate a web-accessible research resource with all the data, methods, and results collected
from the co-clinical investigations. Developing the proposed imaging test could represent a significant
breakthrough for clinicians as a new means for treatment stratification and new gold-standard imaging test for
predicting treatment response of novel immunotherapies. Our QI imaging test could be utilized to compare
the efficacy of different immune-modulating therapies in preclinical settings and translate the most primising
candidates to the clinic. Since the development of new therapeutic drugs is expensive and take years to
complete, the immediate value and heath care impact of our QI tool could be immense.
肿瘤相关巨噬细胞成像联合临床研究资源
摘要
用于监测癌症治疗反应的定量成像(QI)方法的发展
对新的癌症疗法的发展起到了革命性的作用。齐的努力将成像定位为
癌症治疗反应评估临床试验设计中的一个关键因素。因此,有
学术界和工业界对使用网上可访问的研究资源和
为下一代临床试验制定一致的方法来验证QI方法。这是
尤其与癌症免疫疗法的评估有关,因为免疫疗法不会导致
肿瘤体积缩小,至少不是在治疗后的即刻阶段。因此,我们迫切需要新的
QI工具,可以监测肿瘤对新的免疫疗法的反应。我们项目的总体目标是
优化和验证用于体内肿瘤量化的临床前和临床成像技术
骨肉瘤中的相关巨噬细胞()。最近的证据表明,丰厚的
骨肉瘤微环境中的反应可用于直接攻击癌细胞。
封闭肉瘤细胞表达的细胞表面分子CD47导致吞噬细胞激活
的抗癌活性和有效根除骨肉瘤小鼠模型中的肿瘤细胞。26
临床前研究已经完成,目前正在规划多中心I期临床试验,
预计开始日期为2021年。为了解决临床上对QI工具的未得到满足的需求,以监测对新的的反应-
为了调整治疗方法,我们团队开发了一种定量成像测试,它依赖于静脉注射
注射补充铁剂阿魏酸甘油。阿魏酸甲酯是由氧化铁纳米颗粒组成的,
可被吞噬,可用T2加权磁共振45进行定量。由于阿魏酸甲酯是FDA批准的
并可作为的生物标志物,立即投入临床使用。我们向大家展示了
在21只小鼠模型和25名患者中,阿魏酸甘油酯核磁共振可以检测到骨肉瘤中的。通过这件事
项目,我们将(A)优化和验证成像的临床前定量成像方法
建立骨肉瘤小鼠模型,(B)在联合临床中实施优化方法
在接受CD47单抗免疫治疗的骨肉瘤患者中进行试验,最后
(C)用收集到的所有数据、方法和结果填充网上可访问的研究资源
从联合临床调查中。开发拟议的成像测试可能代表着一个重要的
临床医生作为治疗分层的新手段和新的金标准影像检查的突破
预测新型免疫疗法的治疗反应。我们的QI成像测试可以用来比较
不同免疫调节疗法在临床前环境中的疗效和翻译最令人满意的
把候选人送到诊所。因为开发新的治疗药物是昂贵的,而且需要数年时间才能
完整,我们的QI工具的直接价值和医疗保健影响可能是巨大的。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Measurement of Tumor T2* Relaxation Times after Iron Oxide Nanoparticle Administration.
氧化铁纳米颗粒给药后肿瘤 T2* 弛豫时间的测量。
- DOI:10.3791/64773
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Ramasamy,ShakthiKumaran;Roudi,Raheleh;Morakote,Wipawee;Adams,LisaC;Pisani,LauraJ;Moseley,Michael;Daldrup-Link,HeikeE
- 通讯作者:Daldrup-Link,HeikeE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heike Elizabeth Daldrup-Link其他文献
Heike Elizabeth Daldrup-Link的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heike Elizabeth Daldrup-Link', 18)}}的其他基金
Advanced Imaging Tools to Assess Cancer Therapeutics in Pediatric
用于评估儿科癌症治疗的先进成像工具
- 批准号:
10360372 - 财政年份:2022
- 资助金额:
$ 63.91万 - 项目类别:
Advanced Imaging Tools to Assess Cancer Therapeutics in Pediatric
用于评估儿科癌症治疗的先进成像工具
- 批准号:
10570915 - 财政年份:2022
- 资助金额:
$ 63.91万 - 项目类别:
Cellular Senescence Network: New Imaging Tools for Arthritis Imaging
细胞衰老网络:关节炎成像的新成像工具
- 批准号:
10907051 - 财政年份:2021
- 资助金额:
$ 63.91万 - 项目类别:
Cellular Senescence Network: New Imaging Tools for Arthritis Imaging
细胞衰老网络:关节炎成像的新成像工具
- 批准号:
10493340 - 财政年份:2021
- 资助金额:
$ 63.91万 - 项目类别:
Cellular Senescence Network: New Imaging Tools for Arthritis Imaging
细胞衰老网络:关节炎成像的新成像工具
- 批准号:
10376536 - 财政年份:2021
- 资助金额:
$ 63.91万 - 项目类别:
Co-Clinical Research Resource for Imaging Tumor Associated Macrophages
肿瘤相关巨噬细胞成像联合临床研究资源
- 批准号:
10304651 - 财政年份:2021
- 资助金额:
$ 63.91万 - 项目类别:
Imaging Chemotherapy-Induced Brain Damage in Pediatric Cancer Survivors
对小儿癌症幸存者化疗引起的脑损伤进行成像
- 批准号:
10054003 - 财政年份:2020
- 资助金额:
$ 63.91万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 63.91万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 63.91万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 63.91万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 63.91万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 63.91万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 63.91万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 63.91万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 63.91万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 63.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 63.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




